Navigation Links
Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
Date:6/2/2008

omplete the Phase 1 and Phase 2 clinical trials for KRX-0401; we may not be able to meet anticipated development timelines for KRX-0401 due to recruitment, clinical trial results, manufacturing capabilities or other factors; and other risk factors identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof. This press release and prior releases are available at http://www.keryx.com. The information in our website is not incorporated by reference into this press release and is included as an inactive textual reference only.

KERYX CONTACT:

Lauren Fischer

Director - Investor Relations

Keryx Biopharmaceuticals, Inc.

Tel: 212.531.5965

E-mail: lfischer@keryx.com


'/>"/>
SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Keryx Biopharmaceuticals Announces Termination of SUN-MACRO Phase 4 Trial
2. Keryx Biopharmaceuticals Announces that the SUN-MICRO Phase 3 Clinical Trial Failed to Meet its Primary Efficacy Endpoint
3. Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial
4. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
5. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
6. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
7. IDM Pharma Announces Phase 2 Follow-Up Data Showing IDM-2101 is Well Tolerated With Positive Survival Trend in Non-Small Cell Lung Cancer Patients
8. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
9. CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma
10. Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer
11. Poniard Announces Positive Preliminary Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in First-Line Treatment of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... , Aug. 31, 2015 Thousands of ... Administration,s neglect of the opioid addiction epidemic at dozens ... first term in 2008, the United States ... and addiction involving prescription opioids and heroin, yet the ... In a strongly worded letter to President Obama ...
(Date:8/31/2015)... 31, 2015  On August 5, 2015, the U.S. ... denied motions to dismiss securities class action ... and certain of its directors. The class actions allege ... dump" scheme to artificially inflate Galena,s stock price, and ... price was inflated, sold massive amounts of their personally-held ...
(Date:8/31/2015)... 2015  Diplomat Pharmacy, Inc. (NYSE: DPLO ), the ... Hagerman , Chairman & CEO, and Sean Whelan , ... Mr. Hagerman and Mr. Whelan are scheduled to participate ... Boston on Wednesday, September 9, 2015 at 1:45 ... also scheduled to participate in the Robert W. Baird 2015 ...
Breaking Medicine Technology:Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2Diplomat to Participate in Upcoming Investor Conferences 2
... Tenn. , May 20 /PRNewswire-FirstCall / -- Cumberland Pharmaceuticals Inc. ... acute care and gastroenterology markets, today announced that Chief Commercial Officer ... Global Life Sciences Conference in New York at 11:30 ... , , , ...
... , May 20 LightLab Imaging, Inc. announced today that ... leading interventional cardiologist and Director of the Interventional Cardiovascular Center at University ... available to hospitals in the United States – Optical Coherence ... Dr. Costa ...
Cached Medicine Technology:Cumberland Pharmaceuticals to Present at Jefferies Global Life Sciences Conference in New York on June 8, 2010 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 2LightLab's C7-XR FD-OCT Intravascular Imaging System Featured on Good Morning America 3
(Date:8/31/2015)... Ohio (PRWEB) , ... August 31, 2015 , ... ... Michael as Vice President, Marketing and Corporate Communications. In this capacity, Michael will ... , CareSource is an industry leader in consumer-focused programs that have contributed to ...
(Date:8/31/2015)... Los Angeles, CA (PRWEB) , ... August 31, 2015 , ... ... to start from and those who are interested in learning more about the procedure ... Dr. Parsa Mohebi. , Internationally recognized hair transplant surgeon Parsa Mohebi will be ...
(Date:8/31/2015)... ... , ... Coast Dental Vista is celebrating its recent grand opening ... p.m. near Albertsons in the Foothill Center, located at 1279 E. Vista Way. There ... Jay Lopp. Call (760) 208-2518 for more details or stop by on September 5. ...
(Date:8/31/2015)... FL (PRWEB) , ... August 31, 2015 , ... The ... quality healthcare to Veterans residing across southwest Florida by hiring more doctors and nurses ... the list of expanded services. , In early July, Dr. Anthony Jabre was selected ...
(Date:8/31/2015)... North Carolina (PRWEB) , ... August 31, 2015 , ... ... Abernethy Laurels on Tuesday, September 1. , “Alive Inside” shadows a social worker ... “MUSIC & MEMORY?.” , “It’s a documentary about bringing music to residents in health ...
Breaking Medicine News(10 mins):Health News:CareSource Names Vice President, Marketing and Corporate Communications 2Health News:Watch a Live Hair Transplant at Parsa Mohebi Hair Restoration’s Open House 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 2Health News:Discover How to Replace Missing Teeth, Reduce Cavities, and Restore Oral Health During Coast Dental’s Open House in Vista, CA on Sept. 5, 2015 3Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 2Health News:Neurosurgeon Selected to Lead Growing Spine Care Program 3Health News:Public Invited to Dementia Documentary Screening at North Carolina Retirement Community 2
... of outdated inspection practices desperately needed, critics say ... system that guarantees the safety of food in the ... new report finds. , Gaps in the food safety ... inconsistencies among agencies protecting food safety, according to the ...
... have a significantly higher risk of developing Alzheimers ... remains unexplained. Now, researchers at the Salk Institute ... for the diabetes Alzheimers interaction. , In ... of Neurobiology of Aging, investigators led by David ...
... becoming three kinds of cardiac cells , , WEDNESDAY, April ... created from mouse skin cells reprogrammed to have the ... researchers at the University of California, Los Angeles. ... induced pluripotent stem (iPS) cells, which don,t involve the ...
... Actually Work in Real ... ... healthcare community, announced the launch of an,innovative new tool that brings patient ... drugs, and eight out of,ten surfing the web for their healthcare information, ...
... lifestyles, WASHINGTON, April 29 Blue Cross ... of all sizes to get,their workers to take ... inactive lifestyles and preventable health conditions,have on the ... companies,are holding lunchtime walks across America as part ...
... Inc.,(NYSE: HI ) today announced that its Board ... traded company of $0.1825 per share,on the company,s common ... of record at the close of business on June ... approve this inaugural dividend is based,on the strength of ...
Cached Medicine News:Health News:Report Slams U.S. Food Safety System 2Health News:Report Slams U.S. Food Safety System 3Health News:Report Slams U.S. Food Safety System 4Health News:Salk study links diabetes and Alzheimer's disease 2Health News:Salk study links diabetes and Alzheimer's disease 3Health News:Mouse Skin Cells Reprogrammed to Act Like Embryonic Stem Cells 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 2Health News:iGuard.org Alters the Face of E-Health: New Web Service Draws 10,000 New Patients Weekly 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 2Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 3Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 4Health News:Blue Cross and Blue Shield Companies to Get Workers Out of The Office and on Their Feet in All 50 States 5Health News:Hillenbrand, Inc. Declares First Quarterly Dividend As a New Publicly Traded Company 2
Distinct male and female designs for proper anatomical fit. Hip and pelvic components sized independently. Rigid posterior tongue minimizes pelvic rotation. Available in black or white plastic. Aggre...
... B3 Triplanar hip joint is ... - extension, abduction - Ad-duction, ... our Boston Post-Op Hip Orthosis. ... custom Hip Spicas in both ...
... advance in walker design in years. A real step ... bearing surfaces of the foot rest on adaptive areas ... heel strike. The footbed in the sole conforms to ... and stability. , ,No leg length discrepancy; Heel ...
... The High Tide walker provides comfortable stability ... of the lower leg, stress fractures of ... fractures of the ankle. Extension pads for ... patients.The shorter Low Tide walker with midcalf ...
Medicine Products: